Canada markets closed

Merrimack Pharmaceuticals, Inc. (MACK)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
15.00-0.03 (-0.20%)
At close: 04:00PM EDT
15.00 0.00 (0.00%)
After hours: 06:09PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
-
-
-
-
0
Selling General and Administrative
2,176
2,176
2,174
2,616
5,012
Total Operating Expenses
2,176
2,176
2,174
2,616
5,012
Operating Income or Loss
-2,176
-2,176
-2,174
-2,616
-5,012
Interest Expense
-
-
-
-
0
Total Other Income/Expenses Net
139
139
445
144
1,948
Income Before Tax
-1,169
-1,169
-1,541
-2,452
-3,014
Income Tax Expense
12
12
3
3
14
Income from Continuing Operations
-1,181
-1,181
-1,544
-2,455
-3,028
Net Income
-1,181
-1,181
-1,544
-2,455
-3,028
Net Income available to common shareholders
-1,181
-1,181
-1,544
-2,455
-3,028
Basic EPS
-0.10
-0.08
-0.11
-0.18
-0.23
Diluted EPS
-0.10
-0.08
-0.11
-0.18
-0.23
Basic Average Shares
14,183
14,299
13,524
13,407
13,380
Diluted Average Shares
14,183
14,299
13,524
13,407
13,380